Leila Karimi

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Effectiveness of the Local Additional Risk Minimisation Measures for Yellow Fever Vaccine in the United Kingdom: A Survey of Healthcare Professionals and Vaccinees.

Effectiveness of the Local Additional Risk Minimisation Measures for Yellow Fever Vaccine in the United Kingdom: A Survey of Healthcare Professionals and Vaccinees.

Journal: Pharmacoepidemiology and drug safety

Published: May 13, 2025

Impact of European Union label changes to avoid inadvertent use of medicinal products containing methotrexate for once-weekly administration: A survey amongst prescribers, pharmacists and patients on awareness, knowledge, and behaviour.

Impact of European Union label changes to avoid inadvertent use of medicinal products containing methotrexate for once-weekly administration: A survey amongst prescribers, pharmacists and patients on awareness, knowledge, and behaviour.

Journal: Pharmacoepidemiology and drug safety

Published: March 22, 2023

Impact of European Union Label Changes for Fluoroquinolone-Containing Medicinal Products for Systemic and Inhalation Use: Post-Referral Prescribing Trends.

Impact of European Union Label Changes for Fluoroquinolone-Containing Medicinal Products for Systemic and Inhalation Use: Post-Referral Prescribing Trends.

Journal: Drug safety

Published: March 01, 2023

Association of bronchial steroid inducible methylation quantitative trait loci with asthma and chronic obstructive pulmonary disease treatment response.

Association of bronchial steroid inducible methylation quantitative trait loci with asthma and chronic obstructive pulmonary disease treatment response.

Journal: Clinical and translational allergy

Published: August 29, 2022

Identification of ROBO2 as a Potential Locus Associated with Inhaled Corticosteroid Response in Childhood Asthma.

Identification of ROBO2 as a Potential Locus Associated with Inhaled Corticosteroid Response in Childhood Asthma.

Journal: Journal of personalized medicine

Published: July 18, 2021

Effect of β-blockers on the risk of COPD exacerbations according to indication of use: the Rotterdam Study.

Effect of β-blockers on the risk of COPD exacerbations according to indication of use: the Rotterdam Study.

Journal: ERJ open research

Published: August 28, 2020

ADRB2 haplotypes and asthma exacerbations in children and young adults: An individual participant data meta-analysis.

ADRB2 haplotypes and asthma exacerbations in children and young adults: An individual participant data meta-analysis.

Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

Published: August 27, 2020

Combined analysis of transcriptomic and genetic data for the identification of loci involved in glucocorticosteroid response in asthma.

Combined analysis of transcriptomic and genetic data for the identification of loci involved in glucocorticosteroid response in asthma.

Journal: Allergy

Published: April 29, 2020

Genome-wide association study of asthma exacerbations despite inhaled corticosteroid use.

Genome-wide association study of asthma exacerbations despite inhaled corticosteroid use.

Journal: The European respiratory journal

Published: February 17, 2020

IL1RL1 gene variations are associated with asthma exacerbations in children and adolescents using inhaled corticosteroids.

IL1RL1 gene variations are associated with asthma exacerbations in children and adolescents using inhaled corticosteroids.

Journal: Allergy

Published: November 23, 2019

Prevalence and incidence of, and risk factors for chronic cough in the adult population: the Rotterdam Study.

Prevalence and incidence of, and risk factors for chronic cough in the adult population: the Rotterdam Study.

Journal: ERJ open research

Published: November 01, 2019

β2-Adrenergic Receptor (ADRB2) Gene Polymorphisms and Risk of COPD Exacerbations: The Rotterdam Study.

β2-Adrenergic Receptor (ADRB2) Gene Polymorphisms and Risk of COPD Exacerbations: The Rotterdam Study.

Journal: Journal of clinical medicine

Published: August 08, 2019

Showing 1-12 of 16

Last Updated: 09/26/2026